Nuclear ErbB-2 expression as a novel biomarker and therapeutic target in TNBC

Last updated 27th Feb 2019
Follow pinboard


A pinboard by Florencia Chervo

Post-doctoral fellow, Institute of Biology and Experimental Medicine (IBYME-CONICET) Buenos Aires, Argentina


Molecular biology, genomics and clinical research working to reveal nuclear ErbB-2 function in TNBC

My current research focuses on the rol of nuclear ErbB-2/HER2 receptor as a novel clinical biomarker and therapeutic target in triple negative breast cancer (TNBC). TNBC refers to the group of tumo...